Navigation Links
Par Pharmaceutical Reports First Quarter 2008 Results
Date:5/8/2008

/A>.

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward-looking. Such forward-looking statements are those that include estimates, projections, statements regarding the plans and objectives of management, as well as the assumptions underlying the forward-looking statements, and other statements that cannot be verified without reference to future developments or events. The forward-looking statements identified in the release include, but are not limited to, the statements that contain the words "expect," "expected," "anticipate," "anticipates," "anticipated," "projections," "projected," "estimate," estimates," "believes," "continue," and growing." The forward-looking statements in the release are subject to risks and uncertainties, including the Company's ability to accurately value its key generic pipeline products, including, but not limited to the vagaries of litigation, securing regulatory approval and uncertainty of exclusivity, the extent and impact of litigation arising out of the accounting issues described in the Company's filings with the Securities and Exchange Commission (SEC), the difficulty of predicting FDA filings and approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, uncertainty of patent litigation filed against the Company, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks and uncertainties detailed from time to time in the Company's filings with the SEC, such as the Company's reports on Form 10-K, Form 10-Q and Form 8-K, and amendments thereto. Any forward-looking statements inc
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Vion Pharmaceuticals to Appeal Nasdaq Delisting
2. Amneal Pharmaceuticals Receives US FDA Approval for Three Generic Prescription Drugs; Two Using New FDA Electronic Filing Format
3. AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
4. Par Pharmaceutical Acquires Spectrum Pharmaceuticals Interest In Sumatriptan Injection
5. ISTA Pharmaceuticals to Present at the Bank of America 2008 Health Care Conference
6. Cadient Group Continues Winning Streak; Receives Multiple Honors at 2008 Pharmaceutical Advertising and Marketing Excellence Awards
7. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
8. Par Pharmaceutical to Host First Quarter 2008 Earnings Conference Call on May 9 at 9:00 AM
9. ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results
10. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
11. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... a radiology department and distributed through the medical director,s office, ... to significantly reduce the number of unnecessary cervical spine radiographs ... in the July issue of the Journal of the ... At the University of Rochester Medical Center in Rochester, NY, ...
... people worldwide do not have adequate access to surgical ... School of Public Health (HSPH). The researchers also found ... access to operating theatres (surgery sites) than those living ... settings often lack essential equipment. , A substantial ...
... When it comes to executing items on tomorrow,s to-do list, ... say psychologists at Washington University in St. Louis. People ... their intentions much better than people who try to execute ... that sleep enhances our ability to remember to do something ...
... By Jenifer Goodwin HealthDay Reporter , WEDNESDAY, ... disease patients who received fetal cell transplants in the ... can prevent the troublesome side effect. The findings ... said. "These findings lend much optimism to new ...
... There are 8.3 million children who are 5 years ... to formal education, can media intervention make a positive ... Sesame Workshop, which produces Kilimani Sesame, the Tanzanian version ... Hopkins Bloomberg School of Public Health in full collaboration ...
... ... , ... (PRWEB) June 30, 2010 -- Greenway Medical Technologies, Inc., provider of the integrated, single-database ... awarded a patent for its innovative template builder module used to create custom clinical ...
Cached Medicine News:Health News:Top down approach helps academic medical center reduce unnecessary emergency department X-rays 2Health News:More than 2 billion people worldwide lack access to surgical services 2Health News:Memory links to 40 winks 2Health News:Memory links to 40 winks 3Health News:Memory links to 40 winks 4Health News: Parkinson's Transplant Mystery Solved, Researchers Say 2Health News: Parkinson's Transplant Mystery Solved, Researchers Say 3Health News:Kilimani Sesame has positive impact on children in Tanzania: Johns Hopkins University study 2Health News:Greenway Awarded U.S. Patent For EHR Functionality and Workflow 2Health News:Greenway Awarded U.S. Patent For EHR Functionality and Workflow 3Health News:Greenway Awarded U.S. Patent For EHR Functionality and Workflow 4
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
All Keeler magnifiers and telescope are available on a clip to fit over the patient's own spectacle...
This set offers the full range of Keeler magnifiers and telescopes....
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
Significantly more compact and tidier in overall looks yet retain many of the excellent features of the more comprehensive Haag type systems., ,Filters include Cobalt blue; green (red free); neut...
Medicine Products: